Conference Coverage
June 11, 2024
Integrating Palliative Care Education Into Hematology-Oncology Fellowships
2024 ASCO Annual Meeting
June 10, 2024
Osimertinib Therapy Poised to Become New Standard of Care for Unresectable Stage III EGFR-Mutated NSCLC
2024 ASCO Annual Meeting
June 10, 2024
LEAP-001: Study Misses Endpoints but Still Shows Benefit for Lenvatinib/Pembrolizumab in Endometrial Cancer Subsets
SGO 2024 Annual Meeting on Womens Cancer
June 10, 2024
Innovative Staging System for De Novo Metastatic Breast Cancer Validated Internationally
2024 Society of Surgical Oncology Annual Meeting
June 06, 2024
Study Finds Early Menopause May Be Linked to Greater Risk of Breast and Ovarian Cancers
ENDO 2024
June 05, 2024
Impact of High Blood Insulin Levels on Triple-Negative Breast Cancer Survival in Black Women
ENDO 2024
May 29, 2024
Innovative Staging System for De Novo Metastatic Breast Cancer Validated Internationally
2024 Society of Surgical Oncology Annual Meeting
May 24, 2024
NCCN Clinical Practice Guidelines in Oncology: 2024 Updates
2024 NCCN Annual Conference
May 24, 2024
Study Reveals Potential Overtreatment of DCIS in Older Women With Limited Life Expectancy
2024 Society of Surgical Oncology Annual Meeting
May 24, 2024
Is a Test for Early Detection of Pancreatic Cancer on the Horizon?
AACR Annual Meeting 2024
May 24, 2024
Novel Approaches Show Early Activity in Endocrine-Resistant Breast Cancer
2024 Miami Breast Cancer Conference
May 22, 2024
Survival Outcomes Following Adjuvant Therapy in Patients With Clinical T2N0 Rectal Adenocarcinoma
Digestive Disease Week 2024
May 13, 2024
Oral Rinse Could Provide Early Screening for Gastric Cancer
Digestive Disease Week 2024
May 13, 2024
Colorectal Cancer Incidence Is Rising Among Teenagers and Young Adults
Digestive Disease Week 2024
May 13, 2024
Celebrating Excellence: Matthijs Oudkerk, PhD, MD, MSc, Honored for Contributions to Cancer Prevention and Research
Quantitative Imaging Workshop XX
May 09, 2024
Bispecific Antibody Plus Chemotherapy Improves Survival in Patients With Gastric or Gastroesophageal Junction Cancer
AACR Annual Meeting 2024
May 07, 2024
Novel Urine Biomarker Test May Reduce Unnecessary Cystoscopies in Patients With Bladder Cancer
European Association of Urology Congress 2024
May 03, 2024
Can Artificial Intelligence Predict Treatment Response and Outcomes in Breast Cancer?
2024 Miami Breast Cancer Conference
April 25, 2024
Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers
2024 Multidisciplinary Head and Neck Cancers Symposium
April 22, 2024
Bispecific Immune Checkpoint Inhibitor Improves Survival in Patients With Gastric Cancer, Regardless of PD-L1 Status
AACR Annual Meeting 2024
April 12, 2024
Improving Adjuvant Treatment in Patients With Muscle-Invasive Urothelial Carcinoma
European Association of Urology Congress 2024
April 12, 2024
The Lancet Commission on Prostate Cancer: Strategies to Prepare for Predicted Increases in Disease Burden by 2040
European Association of Urology Congress 2024
April 08, 2024
Undocumented Cost-of-Care Discussions: A Missed Opportunity in Cancer Treatment
2023 ASCO Quality Care Symposium
April 05, 2024
Pembrolizumab May Improve Breast Cancer Outcomes Regardless of Age or Menopausal Status
2024 EBCC
March 22, 2024
Addition of Atezolizumab to Adjuvant Chemotherapy in Triple-Negative Breast Cancer
2024 EBCC
March 19, 2024
ChatGPT May Accurately Answer Common Patient Questions Regarding Gynecologic Cancer
SGO 2024 Annual Meeting on Womens Cancer
March 12, 2024
HPV-Associated Oropharyngeal Cancer: Intratreatment FDG-PET Response as a Biomarker for De-escalation of Radiotherapy
2024 Multidisciplinary Head and Neck Cancers Symposium
March 11, 2024
Olaparib Plus Abiraterone and Prednisone Improves Outcomes Over Single Agents in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
2024 ASCO GU Cancers Symposium
March 05, 2024
HPV-Associated Oropharyngeal Cancer: Adjuvant Treatment Deintensification
2024 Multidisciplinary Head and Neck Cancers Symposium
February 28, 2024
Patients With Advanced Breast Cancer May Gain Multiple Benefits From Exercise as Part of Palliative Care
2023 SABCS
February 28, 2024
NATALEE Trial: Long-Term Results on Ribociclib Combination Therapy in Early-Stage Breast Cancer
2023 SABCS
February 23, 2024
All-Oral Regimen Feasible and Effective in Acute Promyelocytic Leukemia, Study Finds
2023 ASH
February 16, 2024
AUGMENT-101 Trial: Menin Inhibitor Revumenib Shows Activity in KMT2A-Rearranged Acute Leukemia
2023 ASH
February 15, 2024
Do Patients With Molecular MRD Detected After Colorectal Cancer Surgery Benefit From Adjuvant Chemotherapy?
2024 ASCO GI Cancers Symposium
January 30, 2024
Immune Checkpoint Inhibitor–Based Therapy May Have Comparative Efficacy in Black and White Patients With Metastatic Renal Cell Carcinoma
2024 ASCO GU Cancers Symposium
January 25, 2024
Integrated Medicine and Collaborative Care: Innovations in Cancer Treatment and Mental Health Care
2023 ASCO Quality Care Symposium
January 25, 2024
ALL in Adults: Trial Updates and Clinical Considerations for Selecting Consolidation Therapy
2023 NCCN Annual Congress: Hematologic Malignancies
January 24, 2024
Study Finds Majority of Patients With Lynch Syndrome Are Not Using Aspirin to Reduce Risk of Colon Cancer
2024 ASCO GI Cancers Symposium
January 03, 2024
Phase III Trial Shows Novel Four-Drug Regimen Improves Survival Outcomes in Extensive-Stage Small Cell Lung Cancer
IASLC 2023 WCLC
December 21, 2023
International Collaborative Research Efforts in Cardio-oncology: Focus on Basic and Translational Science
2023 Global Cardio-Oncology Summit
December 11, 2023
Antibody-Drug Conjugate Makes Progress as Second-Line Therapy for Advanced NSCLC
ESMO Congress 2023
December 11, 2023
Understanding the Treatment Options for PD-1–Refractory Melanoma
2023 Debates and Didactics in Hematology and Oncology Conference
November 30, 2023
First-Line Selpercatinib: New Standard of Care for RET-Positive Medullary Thyroid Cancer?
ESMO Congress 2023
November 22, 2023
Cardiac Imaging and Biomarkers for Patients Receiving Cancer Treatment: What Oncologists Need to Know
2023 Global Cardio-Oncology Summit
November 22, 2023
Adjuvant Everolimus Improves Recurrence-Free Survival in Very High–Risk Renal Cell Carcinoma
ESMO Congress 2023
November 17, 2023
Extensive-Stage Small Cell Lung Cancer: Triplet Combination vs Chemotherapy Alone
IASLC 2023 WCLC
October 31, 2023
Patients With Newly Diagnosed NSCLC or Melanoma May Receive Limited Documentation of Treatment Cost Discussions
2023 ASCO Quality Care Symposium
October 25, 2023
NATALEE Trial: Quality of Life Maintained for Many Patients Treated With Ribociclib for Early-Stage Breast Cancer
2023 ESMO Virtual Plenary
October 25, 2023
The New Era of Perioperative Therapy in Non–Small Cell Lung Cancer
2023 Debates and Didactics in Hematology and Oncology Conference
October 17, 2023
Overall Survival in Two Monarch Trials of Abemaciclib in Advanced Breast Cancer
ESMO Congress 2022
October 17, 2023
Can Younger Women With Hormone Receptor–Positive Breast Cancer Safely Pause Endocrine Therapy to Pursue Pregnancy?
2022 San Antonio Breast Cancer Symposium
October 17, 2023
SOFT Analysis: Breast Cancer Index May Identify Which Patients Need Ovarian Suppression
2022 San Antonio Breast Cancer Symposium
October 17, 2023
EMERALD Trial: Elacestrant vs Standard Endocrine Monotherapy for Advanced Breast Cancer After CDK4/6 Inhibition
2022 San Antonio Breast Cancer Symposium
October 17, 2023
Should CDK4/6 Inhibitors Be a First-Line Option for Advanced Hormone Receptor–Positive, HER2-Negative Breast Cancer?
2023 ASCO Annual Meeting
October 04, 2023
Using Recent Diagnostic Scans May Cut Time to Treatment for Patients Needing Urgent Palliative Radiotherapy
2023 ASTRO Annual Meeting
October 03, 2023
Stereotactic Radiotherapy for Patients With Primary RCC Unsuitable for Surgery: FASTRACK II
2023 ASTRO Annual Meeting
October 03, 2023
Liquid Biopsies May Be Predictive of Cancer Recurrence Following Chemoradiation in Patients With Cervical Cancer
2023 ASTRO Annual Meeting
September 26, 2023
Understanding the Treatment of Waldenström’s Macroglobulinemia
2023 Debates and Didactics in Hematology and Oncology Conference
September 20, 2023
CLL14: Long-Term Results of Fixed-Duration Venetoclax Plus Obinutuzumab in Elderly Patients With CLL
EHA Hybrid Congress 2023
September 14, 2023
Pembrolizumab Plus Chemoradiation Therapy Falls Short in Locally Advanced Head and Neck Cancer
ESMO Congress 2022
September 14, 2023
Cabozantinib Plus Atezolizumab Warrants Further Study in Treatment of Advanced Head and Neck Cancer
SITC 2022
September 14, 2023
Could Fluorouracil-Free First-Line Regimen Challenge the Standard of Care in Advanced Head and Neck Cancer?
ESMO Congress 2022
September 11, 2023
Expert Point of View: Peter Paul Yu, MD, FACP, FASCO
2023 ASCO Breakthrough Meeting
August 24, 2023
Liquid Biopsy Assay Demonstrated Effectiveness in Early Cancer Detection in Asymptomatic Individuals in Vietnam
2023 ASCO Breakthrough Meeting
August 24, 2023
Noninvasive, Multitarget Stool DNA Methylation Assay Under Study in Early Detection of Multiple Gastrointestinal Cancers
2023 ASCO Breakthrough Meeting
August 17, 2023
CARTITUDE-4: Ciltacabtagene Autoleucel Beneficial in Early Myeloma Relapse
2023 ASCO Annual Meeting
August 17, 2023
ZUMA-7: Primary Overall Survival Analysis Supports Axicabtagene Ciloleucel as Second-Line Therapy in Advanced Lymphoma
2023 ASCO Annual Meeting
August 15, 2023
CheckMate 274: Continued Disease-Free Survival Benefits With Adjuvant Nivolumab in High-Risk Urothelial Carcinoma
2023 ASCO Genitourinary Cancers Symposium
July 24, 2023
Two Studies Highlight Benefits in Quality of Life and Symptom Management With Novel Treatments of Advanced Breast Cancer
ESMO Breast Cancer Annual Congress 2023
July 06, 2023
Two Studies of Atezolizumab-Based Regimens in Early-Stage, Triple-Negative and HER2-Positive Breast Cancers
ESMO Breast Cancer Annual Congress 2023
June 23, 2023
In Case You Missed It: Brief Highlights From Studies Presented During AACR 2023
AACR Annual Meeting 2023
June 15, 2023
Novel Hormone Receptor–Driven Therapies Tackling Endocrine Resistance in Breast Cancer
2023 Miami Breast Cancer Conference
June 15, 2023
Surveillance Mammography Rates After Breast Cancer Treatment Remain High, Irrespective of Life Expectancy
24th ASBrS Annual Meeting
June 09, 2023
HER3-Targeting Antibody-Drug Conjugates Show Encouraging Results in Breast Cancer Subtypes
ESMO Breast Cancer Annual Congress 2023
June 07, 2023
Amivantamab Shows Efficacy in Advanced NSCLC With EGFR Exon 20 Insertions
European Lung Cancer Congress 2023
June 07, 2023
CodeBreaK 200: Sotorasib Offers Improved Quality of Life for Patients With Previously Treated NSCLC
European Lung Cancer Congress 2023
May 19, 2023
NCCN Clinical Practice Guidelines in Oncology: 2023 Updates
NCCN 2023 Annual Conference
May 11, 2023
GOG 3026: Durable Responses With Ribociclib Plus Letrozole in Low-Grade Serous Ovarian Cancer
SGO 2023 Annual Meeting on Women’s Cancer
May 04, 2023
Emerging Success With Novel Targeted Therapies in Endocrine-Resistant Metastatic Breast Cancer
2023 Miami Breast Cancer Conference
May 01, 2023
Intraoperative vs Postoperative Lymph Node Pathology Evaluation in Patients With Breast Cancer Undergoing Mastectomy
24th ASBrS Annual Meeting
May 01, 2023
Does Surveillance Mammography Benefit Geriatric Patients With Breast Cancer?
24th ASBrS Annual Meeting
April 25, 2023
Early-Stage Triple-Negative Breast Cancer: Optimizing Therapy
2023 Miami Breast Cancer Conference
April 17, 2023
Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma
AACR Annual Meeting 2023
April 12, 2023
ELCC 2023: New Data on Amivantamab-vmjw in Patients With Advanced NSCLC and EGFR Exon 20 Insertion Mutations
European Lung Cancer Congress 2023
March 30, 2023
Time-Related and Financial Burdens May Impact Quality of Life for Patients With Gynecologic Cancer
SGO 2023 Annual Meeting on Women’s Cancer
March 29, 2023
Positive Outcomes Demonstrated in Patients With Ovarian Cancer Treated With Olaparib Prior to Surgical Intervention and Subsequent Chemotherapy
SGO 2023 Annual Meeting on Women’s Cancer
March 24, 2023
FORMULA-509: Intensified Postoperative Regimen May Be of Benefit in Subset of High-Risk Prostate Cancer
2023 ASCO Genitourinary Cancers Symposium
March 14, 2023
Novel Urine Test May Play a Role in Bladder Cancer Prediction
2023 EAU Annual Congress
March 14, 2023
New Technique May Reduce Postoperative Complications in Prostate Cancer Surgery
2023 EAU Annual Congress
March 13, 2023
PSMA-PET/CT May Help Improve Clinical Treatment of Prostate Cancer
2023 EAU Annual Congress
February 24, 2023
Expert Point of View: Imane H. El Dika, MD
2023 ASCO Gastrointestinal Cancers Symposium
February 16, 2023
Ruxolitinib Demonstrates Clinical Activity in a Phase II Trial of Chronic Myelomonocytic Leukemia
2022 ASH Annual Meeting and Exposition
February 16, 2023
Expert Point of View: Alexey Danilov, MD, PhD
2022 ASH Annual Meeting and Exposition
February 16, 2023
CAR T-Cell Therapy vs Chemoimmunotherapy in Second-Line Treatment of Resistant Large B-Cell Lymphoma
2022 ASH Annual Meeting and Exposition
February 13, 2023
Subset of Patients With Advanced Gastric Cancer May Benefit From Claudin18.2-Targeted Agent Zolbetuximab
2023 ASCO Gastrointestinal Cancers Symposium
January 31, 2023
Subset of Patients With Advanced Gastric/GEJ Cancer May Benefit From CLDN18.2-Targeted Drug Zolbetuximab: SPOTLIGHT Study
2023 ASCO Gastrointestinal Cancers Symposium
January 31, 2023
How Experts Treat Mantle Cell Lymphoma in First Complete Response
2022 Pan Pacific Lymphoma Conference
January 25, 2023
Cabozantinib Plus Atezolizumab Warrants Further Study in Treatment of Advanced Head and Neck Cancer
SITC 2022
January 25, 2023
Study Finds Immune Checkpoint Inhibitors Safe and Effective for Patients Living With HIV Who Have NSCLC
SITC 2022
January 25, 2022
PI3K Pathway Activation May Underlie Tamoxifen-Associated Uterine Cancer
2021 San Antonio Breast Cancer Symposium
January 04, 2022
Identifying Women With Triple-Negative Breast Cancer Who May Benefit From Pembrolizumab Plus Chemotherapy
2021 San Antonio Breast Cancer Symposium
December 21, 2021
Expert Point of View: Matthew J. Ellis, MB, BChir, PhD, FACP
2021 San Antonio Breast Cancer Symposium
December 21, 2021
Composite Biomarker Needed to Predict Benefit of Immunotherapy in Triple-Negative Breast Cancer
2021 Lynn Sage Breast Cancer Symposium
November 10, 2021
Many Patients With Solid Tumors Mount an Adequate Response to SARS–CoV-2 Vaccine, Dutch Study Reports
ESMO Congress 2021
October 13, 2021
Novel HER2-Targeted Therapies Pose Sequencing Challenges
38th Annual Miami Breast Cancer Conference
October 13, 2021
Neoadjuvant Durvalumab Improves Long-Term Outcomes in the GeparNuevo Trial
2021 ASCO Annual Meeting
October 10, 2021
Benefits Seen With Lurbinectedin Plus Doxorubicin in Small Cell Lung Cancer—but Primary Endpoint Missed
IASLC 2021 World Conference on Lung Cancer
September 24, 2021
BRAF-Mutant Colorectal Cancer: Latest Findings for Targeted Treatment
ESMO World Congress on Gastrointestinal Cancer 2021
September 16, 2021
CheckMate 648: First-Line Nivolumab Regimens Improve Survival in Esophageal Squamous Cell Carcinoma
2021 ASCO Annual Meeting
September 10, 2021
Safety, Efficacy of Neoadjuvant Pertuzumab Plus Trastuzumab Maintained in Final Analysis of BERENICE Trial
ESMO Breast Cancer Virtual Congress 2021
September 01, 2021
Neoadjuvant Durvalumab Improves Long-Term Outcomes in the GeparNuevo Trial
2021 ASCO Annual Meeting
August 16, 2021
Phase III GLOW Trial: Improved Outcomes With First-Line Ibrutinib Plus Venetoclax in Elderly Patients With CLL
EHA 2021 Virtual Congress
August 16, 2021
Zanubrutinib Superior to Ibrutinib for CLL/SLL in Phase III ALPINE Trial
EHA 2021 Virtual Congress
July 26, 2021
Lessons From the Pandemic: How COVID-19 Can Lead to Improvements in Cancer Care
NCCN Virtual Oncology Policy Summit
June 11, 2021
Adjuvant Imatinib Therapy Offers Survival Benefit in Patients With Resected GIST, but Team Effort May Be Needed to Reduce Early Discontinuation Rates
SSO 2021 International Conference on Surgical Cancer Care
June 10, 2021
Global Responses to COVID-19 Pandemic–Related Disruptions in Cancer Care
SSO 2021 International Conference on Surgical Cancer Care
June 10, 2021
Actionable Mutations Identified in Majority of Genome-Sequenced Resected Cholangiocarcinomas
SSO 2021 International Conference on Surgical Cancer Care
June 10, 2021
Expert Point of View: Thomas Herzog, MD
SGO 2021 Virtual Annual Meeting on Womens Cancer
June 10, 2021
Could Risk-Based Triage System Alter Surgical Practice in Ovarian Cancer?
SGO 2021 Virtual Annual Meeting on Womens Cancer
June 10, 2021
New Approaches Needed for Patients With Locoregional Breast Cancer Progression During Neoadjuvant Systemic Therapy
22nd ASBrS Annual Meeting
June 10, 2021
Selected Poster Presentations From the NCCN 2021 Annual Conference
NCCN 2021 Virtual Annual Conference
May 27, 2021
2021 Genitourinary Cancers Symposium: Advancements in the Care of Older Adults With Prostate Cancer
2021 Genitourinary Cancers Symposium
May 27, 2021
Single-Agent Pembrolizumab Yields High Response Rates in Patients With Cutaneous Squamous Cell Carcinoma
AACR Annual Meeting 2021
May 25, 2021
Study Finds Ixabepilone Plus Bevacizumab Active in Platinum-Resistant or Recurrent Ovarian Cancer
SGO 2021 Virtual Annual Meeting on Womens Cancer
May 25, 2021
Dual BRAF/MEK Inhibition Under Study in BRAF V600E–Mutant Gliomas
AACR Annual Meeting 2021
May 25, 2021
NCCN Clinical Practice Guidelines in Oncology: 2021 Updates
NCCN 2021 Virtual Annual Conference
April 21, 2021
Adding Apalutamide to Abiraterone/Prednisone Extends Radiographic Progression-Free but Not Overall Survival
2021 Genitourinary Cancers Symposium
April 21, 2021
First-Line Nivolumab Plus Cabozantinib Improves Outcomes vs Sunitinib in Advanced Renal Cell Carcinoma
ESMO Virtual Congress 2020
April 09, 2021
Cardiovascular Risks Associated With Checkpoint Inhibitors and CAR T-Cell Therapy
2021 ACC Conference on Advancing the Cardiovascular Care of the Oncology Patient
March 18, 2021
Oncologist Survey Identifies Knowledge Gaps in Cholangiocarcinoma Mutations
2021 Gastrointestinal Cancers Symposium
March 10, 2021
Novel Therapies Under Study in Chronic Myeloid Leukemia
2020 ASH Annual Meeting & Exposition
March 10, 2021
In Cholangiocarcinoma, Does Chemotherapy Response Vary According to FGFR2 Status?
2021 Gastrointestinal Cancers Symposium
March 10, 2021
Fallout From COVID-19: Decline in Cancer Screening and Increase in Cancer-Related Deaths
AACR Virtual Meeting: COVID-19 and Cancer 2021
February 10, 2021
Severity of Patients’ Symptoms May Be Underrecognized During and After Breast Radiotherapy
2020 San Antonio Breast Cancer Symposium
February 10, 2021
Expert Point of View: Virginia Kaklamani, MD
2020 San Antonio Breast Cancer Symposium
February 10, 2021
Anti–PD-1 Antibody Dostarlimab Active in Mismatch Repair–Deficient Gastrointestinal Tumors
2021 Gastrointestinal Cancers Symposium
January 25, 2021
A Tale of Two CDK4/6 Inhibitors in Early Breast Cancer
2020 San Antonio Breast Cancer Symposium
January 25, 2021
Oral Azacitidine Is Noninferior to Placebo for Health-Related Quality of Life in AML
2020 ASH Annual Meeting & Exposition
January 25, 2021
Expert Point of View: Ajay K. Nooka, MD, MPH
2020 ASH Annual Meeting & Exposition